| Literature DB >> 28920417 |
Kondreddy Eswar Reddy1, Woong Lee1, Jin Young Jeong1, Yookyung Lee1, Hyun-Jeong Lee1, Min Seok Kim1, Dong-Woon Kim1, Dongjo Yu2, Ara Cho3, Young Kyoon Oh1, Sung Dae Lee1.
Abstract
OBJECTIVE: Fusarium mycotoxins deoxynivalenol (DON) and zearalenone (ZEN), common contaminants in the feed of farm animals, cause immune function impairment and organ inflammation. Consequently, the main objective of this study was to elucidate DON and ZEN effects on the mRNA expression of pro-inflammatory cytokines and other immune related genes in the kidneys of piglets.Entities:
Keywords: Deoxynivalenol; Gene Expression; Immune System; Kidney; Pig; Zearalenone
Year: 2017 PMID: 28920417 PMCID: PMC5756916 DOI: 10.5713/ajas.17.0454
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Figure 1The number of up- and downregulated differentially expressed genes (DEGs) among the control, deoxynivalenol (DON), and zearalenone (ZEN) groups. The Y-axis represents the up- and downregulation of DEGs between control kidneys vs mycotoxin-treatment group kidneys. The X-axis represents the total number of transcripts (DEGs for each pairwise comparison were selected at fold change ≥2 and p≤0.05).
Top biological process GO terms of DEGs, obtained from the comparison between the control group and DON- and ZEN-treated groups
| Name | GO ID | Term | Count | Genes | p-value |
|---|---|---|---|---|---|
| Biological_process | GO:0006955 | Immune response | 4 | 0.002 | |
| Biological_process | GO:0065007 | Biological regulation | 6 | 0.007 | |
| Biological_process | GO:0006954 | Inflammatory response | 3 | 0.007 | |
| Biological_process | GO:0023052 | Signaling | 2 | 0.008 | |
| Biological_process | GO:0070098 | Chemokine-mediated signaling | 3 | 0.009 | |
| Biological_process | GO:0051607 | Defense response to virus | 3 | 0.019 | |
| Biological_process | GO:0050789 | Regulation of biological process | 6 | 0.016 | |
| Biological_process | GO:0043170 | Macromolecule metabolic process | 4 | 0.013 | |
| Biological_process | GO:0007154 | Cell communication | 2 | 0.005 | |
| Biological_process | GO:0006807 | Nitrogen compound metabolic process | 2 | 0.012 | |
| Biological_process | GO:0007165 | Signal transduction | 2 | 0.012 | |
| Biological_process | GO:0050794 | Regulation of cellular process | 6 | 0.023 | |
| Biological_process | GO:0009058 | Biosynthetic process | 2 | 0.028 | |
| Biological_process | GO:0044260 | Cellular macromolecule metabolic process | 4 | 0.028 |
GO, gene ontology; DEGs, differentially expressed genes; DON, deoxynivalenol, ZEN, zearalenone.
Gene ontology ID of the biological process.
Name of the biological term.
Number of significant genes which are involved in biological terms.
Name of the genes which are involved in the particular biological term.
Up- and downregulated genes in the kidney samples of DON (8 mg/kg) and ZEN (0.8 mg/kg) dietary treatment groups of piglets
| Gene name | Description | Log2 FC Up/Down | p-value | Biological process |
|---|---|---|---|---|
| Kinesin family member 20A | +2.11 | 0.045 | Mitotic cytokinesis | |
| Cytochrome P450 1A1 | +2.01 | 0.043 | Toxin metabolic process | |
| IgG heavy chain | +8.43 | 0.021 | NF-kappa B signaling pathway | |
| Biotinidase | +2.50 | 0.04 | Nitrogen compound metabolic process | |
| Hemoglobin subunit mu | +2.18 | 0.026 | Extracellular exosome | |
| Histone H2B type 1 | +2.10 | 0.012 | Innate immune response | |
| Liver carboxylesterase | +6.20 | 0.040 | Carboxylic ester hydrolase activity | |
| Myomesin-2-like | +2.51 | 0.048 | Regulatory mechanisms for expression quantity and temporal appearance | |
| Stathmin 1 | +2.23 | 0.049 | Reason for various cancers | |
| Interleukin 10 receptor, beta | −2.10 | 0.031 | Cytokine-cytokine receptor interaction | |
| Chemokine (C-X-C motif) ligand 9 | −3.27 | 0.017 | Inflammatory response | |
| Chemokine (C-X-C motif) ligand 10 | −2.37 | 0.029 | Inflammatory response | |
| Lysozyme | −2.43 | 0.031 | Lysozyme activity | |
| Carboxylesterase 1 | −5.61 | 0.000 | Hydrolysis of xenobiotics and drugs | |
| ATP-binding cassette sub-family 8 | −2.27 | 0.032 | Pathologies associated, lipid transport | |
| Chemokine (C-C motif) ligand 4 | −2.14 | 0.030 | Inflammatory response | |
| α-aminoadipic semialdehyde dehydrogenase | −2.03 | 0.025 | Detoxification of aldehydes | |
| Complement component 4 binding protein α | −2.10 | 0.019 | Response to immune system | |
| Cytochrome P450 2B22 | −2.38 | 0.034 | Transport, and catabolism, | |
| Insulin like growth factor binding protein 4 | −2.03 | 0.0001 | Regulation of cell growth | |
| Myomesin-2 | −2.07 | 0.025 | Immunoglobulin subtype | |
| Phospholipid transfer protein | −2.00 | 0.017 | Lipid metabolic process | |
| Sulfide quinone reductase-like | −2.31 | 0.033 | Oxidoreductase activity | |
| Bospondin-4 | −4.11 | 0.0001 | Phagosome activity | |
| Cytochrome P450 4X1 | −2.51 | 0.049 | Neurovascular function in the brain | |
| Cytochrome P450 4A24 | −3.20 | 0.029 | catalytic activity of lauric acid and palmitic acid | |
| Oligoadenylate synthetase 2 | −2.72 | 0.049 | Immune response | |
| Receptor-type tyrosine-protein phosphatase C | −2.09 | 0.030 | Regulate a cell growth, and oncogenic transformation. | |
| IgG heavy chain | −10.14 | 0.023 | NF-kappa B signaling pathway, | |
| Ig lambda chain c region | −6.15 | 0.027 | Play in diseases such as cancer and diabetes | |
| Angiopoietin-like 4 | −2.20 | 0.041 | Negative regulation of endothelial cell apoptotic process | |
| Pyruvate dehydrogenase kinase, isozyme 4 | −2.49 | 0.035 | Positive regulation of defense response | |
| Signaling lymphocytic activation molecule-9 | −2.68 | 0.035 | Play a role in the immune response |
DON, deoxynivalenol; ZEN, zearalenone; FC, fold change.
Various KEGG pathways observed in the kidney samples of DON- and ZEN-contaminated dietary treatment groups of piglets
| KEGG ID | KEGG map name | Count | Gene names | p-value |
|---|---|---|---|---|
| 04060 | Cytokine-cytokine receptor interaction | 4 | 0.015 | |
| 01100 | Metabolic pathways | 4 | 0.008 | |
| 04062 | Chemokine signaling pathway | 3 | 0.044 | |
| 04620 | Toll-like receptor signaling pathway | 3 | 0.024 | |
| 00380 | Tryptophan metabolism | 3 | 0.015 | |
| 05152 | Tuberculosis | 2 | 0.043 | |
| 05169 | Epstein-Barr virus infection | 2 | 0.048 | |
| 05204 | Chemical carcinogenesis | 2 | 0.022 | |
| 05322 | Systemic lupus erythematosus | 2 | 0.037 | |
| 04145 | Phagosome | 2 | 0.044 | |
| 04151 | PI3K-Akt signaling pathway | 2 | 0.016 |
KEGG, Kyoto encyclopedia of genes and genomes; DON, deoxynivalenol, ZEN, zearalenone.
KEGG pathway IDs in DON and ZEN treatment groups.
Name of the KEGG pathway which is identified in DON and ZEN treatment groups.
Number of significant genes which is involved in KEGG pathways.
Name of the genes which are involved in the particular KEGG pathways.